Literature DB >> 3940754

Effects of furosemide versus isolated ultrafiltration on extravascular lung water in oleic acid-induced pulmonary edema.

E D Sivak, J Tita, G Meden, M Ishigami, J Graves, J Kavlich, N T Stowe, M O Magnusson.   

Abstract

We studied the effects of no treatment, furosemide treatment, and isolated ultrafiltration on extravascular lung water (ETVL) in mongrel dogs in whom pulmonary edema was induced with oleic acid. In all treatment groups, ETVL was significantly elevated 90 min after oleic acid infusion. At 270 min, we found no difference between nontreatment and furosemide. There was, however, a significant difference between no treatment and ultrafiltration but not between furosemide and ultrafiltration. In spite of observations which suggest that ultrafiltration is of benefit in reducing ETVL, we could not demonstrate superiority of one therapy over another.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3940754     DOI: 10.1097/00003246-198601000-00011

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  4 in total

Review 1.  Fluid management in ARDS: "keep them dry" or does it matter?

Authors:  D P Schuster
Journal:  Intensive Care Med       Date:  1995-02       Impact factor: 17.440

2.  Continuous arteriovenous haemofiltration and respiratory function in multiple organ systems failure.

Authors:  O N Bagshaw; F R Anaes; A Hutchinson
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

3.  Volume assessment in mechanically ventilated critical care patients using bioimpedance vectorial analysis, brain natriuretic Peptide, and central venous pressure.

Authors:  Andrew A House; Mikko Haapio; Paolo Lentini; Ilona Bobek; Massimo de Cal; Dinna N Cruz; Grazia M Virzì; Rizzieri Carraro; Giampiero Gallo; Pasquale Piccinni; Claudio Ronco
Journal:  Int J Nephrol       Date:  2010-12-02

4.  Renal replacement therapy with net fluid removal lowers intra-abdominal pressure and volumetric indices in critically ill patients.

Authors:  Inneke De Laet; Dries Deeren; Karen Schoonheydt; Niels Van Regenmortel; Hilde Dits; Manu Lng Malbrain
Journal:  Ann Intensive Care       Date:  2012-12-20       Impact factor: 6.925

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.